Response to "Poor control vaccines in two randomised trials of malaria vaccine?"

Vaccine

Volumn 27, Issue 35, 2009, Pages 4745-4746

  Bejon, Philip ^a   Abdulla, Salim ^b   Lusingu, John ^c,d   Olotu, Ally ^a   Leach, Amanda ^e   Lievens, Marc ^e   Tanner, Marcel ^b,f   von Seidlein, Lorenz ^c,d,g  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b IFAKARA HEALTH INSTITUTE   (Tanzania)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^d Joint Malaria Programme   (Tanzania)

^e GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^f SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^g International Vaccine Institute   (South Korea)

Author keywords

Falciparum; Hepatitis B; Malaria; Rabies; RTS,S; Safety; Vaccine

Indexed keywords

HEPATITIS B VACCINE; MALARIA VACCINE; RABIES VACCINE; RTS S ASO1E VACCINE; RTS S ASO2D VACCINE; UNCLASSIFIED DRUG;

AFRICA; ANTIBODY RESPONSE; CHILD; CLINICAL TRIAL; FEMALE; HEALTH PROGRAM; HUMAN; INFANT; LETTER; MAJOR CLINICAL STUDY; MALARIA; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT; VACCINATION;

BIOMEDICAL RESEARCH; FEMALE; HUMANS; INFANT; MALARIA; MALARIA VACCINES; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 67650553110     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.05.035     Document Type: Letter

References (8)

1. Aaby P., Ravn H., and Benn C.S. Poor control vaccines in two randomised trials of malaria vaccine?. Vaccine (2009)
2. Bejon P., Lusingu J., Olotu A., Leach A., Lievens M., Vekemans J., et al. Efficacy of RTS, S/AS01E vaccine against malaria in children 5-17 months of age. N Engl J Med 359 24 (2008) 2521-2532
3. Abdulla S., Oberholzer R., Juma O., Kubhoja S., Machera F., Membi C., et al. Safety and immunogenicity of RTS, S/AS02D malaria vaccine in infants. N Engl J Med 359 24 (2008) 2533-2544
4. Manning S.E., Rupprecht C.E., Fishbein D., Hanlon C.A., Lumlertdacha B., Guerra M., et al. Human rabies prevention-United States, 2008 recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 57 RR-3 (2008) 1-28
5. Global progress toward universal childhood hepatitis B vaccination. 52(36). MMWR Morb Mortal Wkly Rep (2003) 868-870
6. Aponte J.J., Aide P., Renom M., Mandomando I., Bassat Q., Sacarlal J., et al. Safety of the RTS, S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial. Lancet 370 9598 (2007) 1543-1551
7. Aaby P., Benn C.S., Nielsen J., Lisse I.M., Rodrigues A., and Jensen H. DTP vaccination and child survival in observational studies with incomplete vaccination data. Trop Med Int Health 12 1 (2007) 15-24
8. Aaby P., Vessari H., Nielsen J., Maleta K., Benn C.S., Jensen H., et al. Sex differential effects of routine immunizations and childhood survival in rural Malawi. Pediatr Infect Dis J 25 8 (2006) 721-727